Berry Genomics Co (SZSE:000710) ROCE % : 3.35% (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Berry Genomics Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Berry Genomics Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 3.35%.

Berry Genomics Co ROCE % Historical Data

The historical data trend for Berry Genomics Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Berry Genomics Co ROCE % Chart

Berry Genomics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

19.61

9.78

-3.92

-9.87

-19.53

Berry Genomics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															0.30	-13.92	8.69	-75.16	3.35

Berry Genomics Co ROCE % Calculation

Berry Genomics Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-437.073	/	( ( (3203.495 - 704.72)	+	(2741.165 - 763.092) )	/ 2 )
	=	-437.073	/	( (2498.775	+	1978.073)	/ 2 )
	=	-437.073	/	2238.424
	=	-19.53 %

Berry Genomics Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	66.368	/	( ( (2741.165 - 763.092)	+	(2699.258 - 713.031) )	/ 2 )
	=	66.368	/	( ( 1978.073	+	1986.227 )	/ 2 )
	=	66.368	/	1982.15
	=	3.35 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Berry Genomics Co (SZSE:000710) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Berry Genomics Co ROCE % Related Terms

Thank you for viewing the detailed overview of Berry Genomics Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Berry Genomics Co (SZSE:000710) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Berry Genomics Co Ltd (SZSE:000710) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Life Park Road, Building 5, Courtyard 4, Science and Technology Park, Changping District, Beijing, CHN

Website

http://www.berrygenomics.com

Berry Genomics Co Ltd is an innovative biotechnology company. It providess gene sequencing detection equipment and services.

Executives

Gao Yang	Directors, executives
Hou Ying	Directors, executives
Wang Yu Jing	Supervisors
Wang Dong	Directors, executives
Zhou Dai Xing	Directors, executives
Ou Yang Xiang Yu	Supervisors
Li Guang Chao	Independent director
Gu Zhong Guo	Directors, executives
Wen Wu	Director
Ding Xian Xing	Supervisors

Berry Genomics Co (SZSE:000710) Headlines

No Headlines